Page last updated: 2024-11-02

pioglitazone and Lichen Ruber Planus

pioglitazone has been researched along with Lichen Ruber Planus in 7 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
"Pioglitazone has been reported as a possible therapeutic option."3.11Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial. ( Azar, PM; Balighi, K; Daneshpazhooh, M; Dasdar, S; Ghiasi, M; Kianfar, N; Lajevardi, V; Peymanfar, AA, 2022)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Lajevardi, V1
Ghiasi, M1
Balighi, K1
Daneshpazhooh, M1
Azar, PM1
Kianfar, N1
Dasdar, S1
Peymanfar, AA1
Peterson, EL1
Gutierrez, D1
Brinster, NK1
Lo Sicco, KI1
Shapiro, J1
Preda-Naumescu, A1
Bevans, SL1
Mayo, TT1
Imanishi, H1
Ansell, DM1
Chéret, J1
Harries, M1
Bertolini, M1
Sepp, N1
Bíró, T1
Poblet, E1
Jimenez, F1
Hardman, J1
Panicker, SP1
Ward, CM1
Paus, R1
Spring, P1
Spanou, Z1
de Viragh, PA1
Mesinkovska, NA1
Tellez, A1
Dawes, D1
Piliang, M1
Bergfeld, W1
Mirmirani, P1
Karnik, P1

Reviews

1 review available for pioglitazone and Lichen Ruber Planus

ArticleYear
Pediatric Lichen Planopilaris Treated With Pioglitazone: A Case Study and Literature Review.
    Journal of drugs in dermatology : JDD, 2021, Jul-01, Volume: 20, Issue:7

    Topics: Alopecia; Child; Humans; Lichen Planus; Pioglitazone; Treatment Outcome

2021

Trials

1 trial available for pioglitazone and Lichen Ruber Planus

ArticleYear
Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial.
    Dermatologic therapy, 2022, Volume: 35, Issue:11

    Topics: Adult; Alopecia; Clobetasol; Female; Humans; Lichen Planus; Male; Pioglitazone; Treatment Outcome

2022

Other Studies

5 other studies available for pioglitazone and Lichen Ruber Planus

ArticleYear
Response of Lichen Planopilaris to Pioglitazone Hydrochloride
    Journal of drugs in dermatology : JDD, 2019, Dec-01, Volume: 18, Issue:12

    Topics: Adult; Aged; Female; Humans; Immunologic Factors; Lichen Planus; Male; Middle Aged; Pioglitazone; PP

2019
Epithelial-to-Mesenchymal Stem Cell Transition in a Human Organ: Lessons from Lichen Planopilaris.
    The Journal of investigative dermatology, 2018, Volume: 138, Issue:3

    Topics: Adult; Aged; Cells, Cultured; Epithelial-Mesenchymal Transition; Female; Humans; Keratin-15; Lichen

2018
Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: lack of lasting improvement or cure in the majority of patients.
    Journal of the American Academy of Dermatology, 2013, Volume: 69, Issue:5

    Topics: Adult; Aged; Female; Humans; Lichen Planus; Male; Middle Aged; Pioglitazone; PPAR gamma; Prospective

2013
The use of oral pioglitazone in the treatment of lichen planopilaris.
    Journal of the American Academy of Dermatology, 2015, Volume: 72, Issue:2

    Topics: Administration, Oral; Alopecia; Disease Progression; Edema; Female; Follow-Up Studies; Humans; Liche

2015
Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist.
    Archives of dermatology, 2009, Volume: 145, Issue:12

    Topics: Alopecia; Humans; Hypoglycemic Agents; Lichen Planus; Male; Middle Aged; Pioglitazone; PPAR gamma; S

2009